Literature DB >> 14738419

Evaluation with alpha-[11C]methyl-L-tryptophan positron emission tomography for reoperation after failed epilepsy surgery.

Csaba Juhász1, Diane C Chugani, Uma N Padhye, Otto Muzik, Aashit Shah, Eishi Asano, Tom J Mangner, Pulak K Chakraborty, Sandeep Sood, Harry T Chugani.   

Abstract

PURPOSE: Reoperation after failed cortical resection can alleviate seizures in patients with intractable neocortical epilepsy, provided that previously nonresected epileptic regions are accurately defined and removed. Most imaging modalities have limited value in identifying such regions after a previous surgery. Positron emission tomography (PET) using alpha-[11C]methyl-L-tryptophan (AMT) can detect epileptogenic cortical areas as regions with increased tracer uptake. This study analyzed whether increased cortical AMT uptake can detect nonresected epileptic foci in patients with previously failed neocortical resection.
METHODS: Thirty-three young patients (age 3-26 years; mean age, 10.8 years) with intractable epilepsy of neocortical origin, and a previously failed cortical resection performed at various epilepsy centers, underwent further presurgical evaluation for reoperation. AMT-PET scans were performed 6 days to 7 years after the first surgery. Focal cortical areas with increased AMT uptake were objectively identified and correlated to ictal EEG data as well as clinical variables (age, postsurgical time, etiology).
RESULTS: Cortical increases of AMT uptake were detected on the side of the previous resections in 12 cases. In two patients scanned shortly (within a week) after surgery, diffuse hemispheric increases were observed, without any further localization value. In contrast, in 10 (43%) of 23 patients scanned >2 months but within 2.3 years after surgery, focal cortical increases occurred, concordant with seizure onset on ictal EEG. Age, etiology (lesional vs. cryptogenic), epileptiform EEG activity during PET, or time of the last seizure were not significantly related to the presence of increased AMT uptake. All patients with localizing AMT-PET, who underwent reoperation, became seizure free (n = 5) or showed considerable improvement of seizure frequency (n = 2).
CONCLUSIONS: AMT-PET can identify nonresected epileptic cortex in patients with a previously failed neocortical epilepsy surgery and, with proper timing for the scan, can assist in planning reoperation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738419     DOI: 10.1111/j.0013-9580.2004.30303.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

Review 1.  α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.

Authors:  Ajay Kumar; Eishi Asano; Harry T Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

2.  Imaging of serotonin mechanisms in epilepsy.

Authors:  Harry T Chugani; Diane C Chugani
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 3.  Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Authors:  Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

4.  Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy.

Authors:  Harry T Chugani; Ajay Kumar; William Kupsky; Eishi Asano; Sandeep Sood; Csaba Juhász
Journal:  Epilepsia       Date:  2011-05-13       Impact factor: 5.864

Review 5.  Utility of MRI, PET, and ictal SPECT in presurgical evaluation of non-lesional pediatric epilepsy.

Authors:  Csaba Juhász; Flóra John
Journal:  Seizure       Date:  2019-05-11       Impact factor: 3.184

6.  Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.

Authors:  Bálint Alkonyi; Sandeep Mittal; Ian Zitron; Diane C Chugani; William J Kupsky; Otto Muzik; Harry T Chugani; Sandeep Sood; Csaba Juhász
Journal:  J Neurooncol       Date:  2011-11-03       Impact factor: 4.130

7.  Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients.

Authors:  Michael Christensen; David Olayinka Kamson; Michael Snyder; Harold Kim; Natasha L Robinette; Sandeep Mittal; Csaba Juhász
Journal:  J Radiat Oncol       Date:  2014-06

8.  Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy.

Authors:  Massoud Akhtari; Anatol Bragin; Mark Cohen; Rex Moats; Frank Brenker; Mattew D Lynch; Harry V Vinters; Jerome Engel
Journal:  Epilepsia       Date:  2008-05-08       Impact factor: 5.864

Review 9.  Rates and predictors of success and failure in repeat epilepsy surgery: A meta-analysis and systematic review.

Authors:  Max O Krucoff; Alvin Y Chan; Stephen C Harward; Shervin Rahimpour; John D Rolston; Carrie Muh; Dario J Englot
Journal:  Epilepsia       Date:  2017-10-10       Impact factor: 5.864

Review 10.  Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.

Authors:  Csaba Juhász; Shalini Dwivedi; David O Kamson; Sharon K Michelhaugh; Sandeep Mittal
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.